| Phase 16 trials |
|
Phase 1
|
NCT06589713 |
Sep 2024 → Apr 2026 |
impaired renal function disease |
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT06589726 |
Sep → Dec 2024 |
— |
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT05110027 |
Nov → Dec 2021 |
— |
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT04880213 |
May → Nov 2021 |
— |
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT04647708 |
Dec 2020 → Dec 2023 |
cutaneous lupus erythematosus, systemic lupus erythematosus |
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT03676322 |
Sep 2018 → Jul 2019 |
— |
Merck KGaA, Darmstadt, Germany |
Completed
|
No outcome recorded
|
| Phase 24 trials |
|
Phase 2
|
NCT05650567 |
Jan 2023 → Jun 2025 |
dermatomyositis |
EMD Serono Research & Development Institute, Inc. |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT05540327 |
Sep 2022 → Aug 2028 expected |
systemic lupus erythematosus |
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT05162586 |
Mar 2022 → Nov 2024 |
systemic lupus erythematosus |
EMD Serono Research & Development Institute, Inc. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT04448756 |
Jul 2020 → Aug 2021 |
COVID-19 |
EMD Serono Research & Development Institute, Inc. |
Completed
|
No outcome recorded
|
| Phase 32 trials |
|
Phase 3
|
NCT07355218 |
Apr 2026 → May 2029 expected |
cutaneous lupus erythematosus, systemic lupus erythematosus |
EMD Serono Research & Development Institute, Inc. |
Recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT07332481 |
Mar 2026 → May 2029 expected |
cutaneous lupus erythematosus, systemic lupus erythematosus |
EMD Serono Research & Development Institute, Inc. |
Recruiting
|
No outcome recorded
|